Isofol Medical, Investor Meeting, 2021

March 22nd 2021 14:00 (Europe/Stockholm)
Language:
English
Speaker:
CEO Ulf Jungnelius
Sector:
Health care - Pharmaceuticals & Biotechnology
Listing:
Small Cap
Activity:
Audiocast with teleconference
Teleconference:
Dial-in number SE: +46850558358 UK: +443333009032 US: 18335268381

Isofol receives recommendation from IDSMB to complete the global phase III agent study for market registration as planned with 440 patients.

Please find more info here.